Skip to content

The effect of electrical stimulation of the brain with virtual reality on people with multiple sclerosis

Effectiveness of transcranial direct current stimulation with virtual reality ?training for balance and fear of falling in people with multiple sclerosis, a ?randomized control trial ?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150411021686N4
Enrollment
36
Registered
2023-12-01
Start date
2024-01-21
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: receiving virtual reality balance exercises with bright tDCS. To use tDCS, a direct stimulation current will be used by a pair of electrodes (cathode and anode). Th

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having MS as diagnosed by a neurologist No history of falling in the last month according to the reference or family report No addiction according to the client's, family or doctor's report Not having obvious orthopedic, rheumatology, or internal problems that the person complains about (such as back pain, hallux valgus, flat feet, foot ulcers) according to the client's report, the family or the client's doctor, if you cause problems in the implementation of the tests People with mild to moderate disability EDSS=1-5 Age range 18-60 years having cognitive impairment (getting a score higher than 21 in the MMSE test)

Exclusion criteria

Exclusion criteria: Corticosteroid use up to 28 days before evaluation based on medical records and patient statements Having mental problems (according to the patient's file) Having a history of attacks and relapses in the last 2 months (according to the patient's file) Having a history of other neurological diseases (according to the patient's file)

Design outcomes

Primary

MeasureTime frame
Balance. Timepoint: before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Biodex.;Fear of falling. Timepoint: before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Fear of falling questionnaire.

Secondary

MeasureTime frame
Fatigue. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Fatigue Severity Scale questionnaire.;Activity of daily living. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Lawton questionnaire.;Postural control. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Force Plate.;Functional mobility. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Time Up & Go test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Ahmadizadeh

Semnan University of Medical Sciences

ahmadizade.z@gmail.com+98 23 3365 4180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026